Karen Slobod

Karen offers more than 20 years of experience in vaccine development at academia and industry. She has substantial experience in the design and conduct of studies of novel viral and bacterial vaccine candidates, in infants, adults, and pregnant women. She previously worked at Novartis Vaccines & Diagnostics in clinical development, advancing programs from first-in-man to Phase 3 planning stages, ultimately assuming lead of a global maternal vaccine program. Following the acquisition of Novartis Vaccines by GSK, she spent a year at a small biotech in Boston, and has worked for the last two years as an independent clinical development consultant, supporting vaccine and infectious disease programs for biotech and academic institutions. Karen obtained her M.D. from McGill University, completed a residency in pediatrics and a fellowship in pediatric infectious diseases, and advanced to associate member at St Jude Children’s Research Hospital in Memphis, Tenn.